Table 2 |
|
|
Indications for the transplant of haematopoietic stem cells |
|
|
Allogenic |
Autologous |
|
|
|
|
Congenital Diseases |
|
|
Congenital combined immunodeficiency |
* |
|
Fanconi's medular aplasia |
* |
|
Talasemia major |
* |
|
Sickle cell |
* |
|
Blackfan-Diamond's erythroblastopenia |
* |
|
Kostmann's neutropenia |
* |
|
Juvenile Osteopetrosis |
* |
|
Thesaurismosis |
* |
|
Chronic Granulomatous Disease |
* |
|
Acquired Neoplastic Diseases |
|
|
Acute Leukemias |
* |
|
Chronic Myeloid Lukemia |
* |
|
Chronic Lymphocytic Leukemia |
* |
|
Non-Hodkin Lymphoma |
* |
|
Hodgkin Lymphoma |
* |
|
Multiple Myeloma |
* |
|
Histiocytosis |
* |
|
Myelodysplastic Syndrome |
* |
|
Solid Tumors |
* |
|
Non-neoplastic acquired diseases |
|
|
Severe Marrow Aplasia |
* |
|
|
|
|
* No indication Table adapted from: Asociación Mexicana de Medicina Transfusional, A.C., Agrupación Mexicana para el Estudio de la Hematología, A.C. Guía para el uso clínico de la sangre. México: Secretaría de Salud; 2007. |
|
|
Serrano-Delgado et al. BMC Medical Ethics 2009 10:12 doi:10.1186/1472-6939-10-12 |
|